Cargando…

Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies

INTRODUCTION: With the emergence of therapeutic complement inhibitors, there is a need to identify patients with complement-driven inflammation. C5b-9 is the terminal product of the three complement pathways and therefore a marker of total complement activation. We present a pilot study which aims t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wijaya, Carolyn, Burns, Christine, Hall, Sharron, Farmer, Melissa, Jones, Denise, Rowlandson, Matthew, Choi, Peter, Formby, Mark, de Malmanche, Theo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124756/ https://www.ncbi.nlm.nih.gov/pubmed/36917968 http://dx.doi.org/10.1159/000529734

Ejemplares similares

INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDE: CONSUMPTION OF EACH OF THE SIX TERMINAL COMPLEMENT COMPONENTS
por: Gewurz, H., et al.
Publicado: (1968)

Complement inhibition by soluble complement receptor type 1 fails to moderate cerulein-induced pancreatitis in the rat
por: Weiser, Martin R., et al.
Publicado: (1996)

The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria
por: Kulasekararaj, Austin G., et al.
Publicado: (2022)

Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking
por: Wu, Lin-Ping, et al.
Publicado: (2021)

Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses
por: Murugaiah, Valarmathy, et al.
Publicado: (2021)

Complement receptor is an inhibitor of the complement cascade
Publicado: (1981)

Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent
por: Bose, Nandita, et al.
Publicado: (2013)

Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components
Publicado: (1989)

Terminal complement activation is increased and associated with disease severity in CIDP
por: Quast, Isaak, et al.
Publicado: (2016)

Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
por: Staels, F., et al.
Publicado: (2022)

Complement
por: Treffers, Henry P.
Publicado: (1966)

Genetic Association of the Porcine C9 Complement Component with Hemolytic Complement Activity
por: Khoa, D. V. A., et al.
Publicado: (2015)

Immunopathology of terminal complement activation and complement C5 blockade creating a pro‐survival and organ‐protective phenotype in trauma
por: Yang, Zhangsheng, et al.
Publicado: (2022)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Modulation of Neutrophil Activity by Soluble Complement Cleavage Products—An In-Depth Analysis
por: Wohlgemuth, Lisa, et al.
Publicado: (2022)

Levels of soluble complement regulators predict severity of COVID-19 symptoms
por: Tierney, Anna L., et al.
Publicado: (2022)

CspA from Borrelia burgdorferi Inhibits the Terminal Complement Pathway
por: Hallström, Teresia, et al.
Publicado: (2013)

Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients
por: Ahmad, Fatima M, et al.
Publicado: (2022)

Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney
por: Tiller, Gesa, et al.
Publicado: (2022)

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
por: Vu, Tuan, et al.
Publicado: (2023)

A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis
por: Sikkeland, Liv I. B., et al.
Publicado: (2023)

COMPLEMENT AND COMPLEMENT-LIKE ACTIVITY IN LOWER VERTEBRATES AND INVERTEBRATES
por: Day, N. K. B., et al.
Publicado: (1970)

Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)

Complement controls the immune synapse and tumors control complement
por: Herbert, Alan
Publicado: (2020)

A novel soluble complement receptor 1 fragment with enhanced therapeutic potential
por: Wymann, Sandra, et al.
Publicado: (2020)

The complement system
por: Sarma, J. Vidya, et al.
Publicado: (2010)

Complementing regeneration
por: Alawieh, Ali, et al.
Publicado: (2015)

Complement or Alexin
Publicado: (1937)

Complement Fixation
Publicado: (1920)

New Compstatin Peptides Containing N-Terminal Extensions and Non-Natural Amino Acids Exhibit Potent Complement Inhibition and Improved Solubility Characteristics
por: Gorham, Ronald D., et al.
Publicado: (2014)

DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE WITH AN INHERITED COMPLEMENT DEFECT
por: Nilsson, Ulf R., et al.
Publicado: (1967)

DEFICIENCY OF THE SIXTH COMPONENT OF COMPLEMENT IN RABBITS WITH AN INHERITED COMPLEMENT DEFECT
por: Rother, Klaus, et al.
Publicado: (1966)

Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway
por: Jiang, Haixiang, et al.
Publicado: (2001)

Standardization of a Complement Fixation Reaction with Chicken Serum as Complement
por: Watson, Barbara K.
Publicado: (1947)

Subject Gaps Revisited: Complement Clauses and Complementizer-Trace Effects
por: Tollan, Rebecca, et al.
Publicado: (2021)

Complement Factor I Variants in Complement-Mediated Renal Diseases
por: Zhang, Yuzhou, et al.
Publicado: (2022)

Hepatocyte Nuclear Factor 1α Controls the Expression of Terminal Complement Genes
por: Pontoglio, Marco, et al.
Publicado: (2001)

Terminal complement complex in porcine septic shock with substantial capillary leak syndrome
por: Cobas-Meyer, M, et al.
Publicado: (2001)

Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway
por: Anliker-Ort, Marion, et al.
Publicado: (2020)

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
por: Carpanini, Sarah M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5usfaer1abmau5u09vgp8dnbp9